Heron Therapeutics (HRTX) Net Cash Flow Growth (1y) (2011 - 2026)
Heron Therapeutics (HRTX) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
198.34% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
467.41% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-14,223.53% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
453.08% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Heron Therapeutics |
76.81 Mn |
46.84 Mn |
24.07 Mn |
61.27% |
| Date | Value |
|---|
| Mar 31, 2026 |
61.27% |
| Dec 31, 2025 |
-23,740.98% |
| Sep 30, 2025 |
261.01% |
| Jun 30, 2025 |
-33.38% |
| Mar 31, 2025 |
20.59% |
| Dec 31, 2024 |
100.99% |
| Sep 30, 2024 |
-65.63% |
| Jun 30, 2024 |
84.85% |
| Mar 31, 2024 |
-170.16% |
| Dec 31, 2023 |
82.37% |
| Sep 30, 2023 |
1,069.87% |
| Jun 30, 2023 |
-64.15% |
| Mar 31, 2023 |
134.87% |
| Dec 31, 2022 |
49.19% |
| Sep 30, 2022 |
105.79% |
| Jun 30, 2022 |
-106.32% |
| Mar 31, 2022 |
25.92% |
| Dec 31, 2021 |
-790.50% |
| Sep 30, 2021 |
-319.27% |
| Jun 30, 2021 |
682.68% |
